Recent News for SRPT - Sarepta Therapeutics, Inc.

Date Title
Sep 17 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, SRPT and MDP
Sep 17 INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Sep 17 CLASS ACTION UPDATE for MNK, CAH, GVA and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 17 Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and Encourages Sarepta Investors to Contact the Firm
Sep 16 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PS, TWOU and SRPT
Sep 16 Sarepta: Risks Are Priced In, Valuation Is Compelling
Sep 16 SHAREHOLDER ALERT: GVA VAL SRPT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Sep 16 GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC
Sep 15 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CAH, IFF and SRPT
Sep 14 SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Sep 13 CLASS ACTION UPDATE for LB, PS and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 13 IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Sep 13 SHAREHOLDER ALERT: KPTI GTT SRPT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Sep 12 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PS, SRPT and TXT
Sep 12 IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Sep 12 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CARB, VAL and SRPT
Sep 12 SHAREHOLDER ALERT: IFF SRPT TXT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Sep 11 CLASS ACTION UPDATE for CARB, EVH and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 11 INVESTOR ALERT - Sarepta Therapeutics, Inc. (SRPT) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: October 29, 2019
Sep 10 Is Sarepta Therapeutics (NASDAQ:SRPT) Weighed On By Its Debt Load?
Sep 9 Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Morgan Stanley 17th Annual Global Healthcare Conference (Transcript)
Sep 9 Here's Why Sarepta Therapeutics Dropped 39.4% in August
Sep 9 CLASS ACTION UPDATE for INS, NFLX and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 9 INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Sep 9 SHAREHOLDER ALERT - Sarepta Therapeutics, Inc. (SRPT) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: October 29, 2019
Back to the Main SRPT Page...